PPARA and metabolic dysfunction-associated steatotic liver disease: Silencing of miR-34a restores the expression of SIRT1 and PPARα, resulting in activation of the metabolic sensor AMP-activated protein kinase (AMPK) and the activation of various PPARα target genes, suggesting a fundamental role of miR-34a in the deregulation of lipid metabolism associated with NAFLD [34].